Pharmaxis Announces Milestone in Phase III Trial for Cystic Fibrosis
1st
Apr 09
Release Date: 01/04/2009 12:00am
Pharmaceutical company Pharmaxis (ASX:PXS, NASDAQ:PXSL) today announced completion of the first component of its Phase III international trial assessing the effectiveness of Bronchitol in people with cystic fibrosis.
Categories: